Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 3 studies | 36% ± 14% | |
erythroblast | 3 studies | 34% ± 9% |
Insufficient scRNA-seq data for expression of PKLR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3992.75 | 226 / 226 | 94% | 121.47 | 380 / 406 |
kidney | 97% | 1226.10 | 86 / 89 | 69% | 16.26 | 625 / 901 |
skin | 62% | 70.38 | 1121 / 1809 | 36% | 7.63 | 169 / 472 |
intestine | 49% | 126.08 | 478 / 966 | 27% | 2.01 | 142 / 527 |
brain | 61% | 44.23 | 1621 / 2642 | 0% | 0.00 | 1 / 705 |
peripheral blood | 43% | 39.32 | 399 / 929 | 0% | 0 | 0 / 0 |
stomach | 3% | 0.44 | 12 / 359 | 29% | 2.92 | 83 / 286 |
spleen | 30% | 14.68 | 72 / 241 | 0% | 0 | 0 / 0 |
lung | 15% | 3.03 | 89 / 578 | 2% | 0.17 | 22 / 1155 |
esophagus | 7% | 1.39 | 97 / 1445 | 7% | 0.69 | 12 / 183 |
bladder | 0% | 0 | 0 / 21 | 10% | 0.88 | 49 / 504 |
adipose | 7% | 1.86 | 82 / 1204 | 0% | 0 | 0 / 0 |
uterus | 5% | 0.66 | 8 / 170 | 2% | 0.08 | 8 / 459 |
thymus | 5% | 0.81 | 34 / 653 | 0% | 0 | 0 / 605 |
eye | 0% | 0 | 0 / 0 | 5% | 0.13 | 4 / 80 |
prostate | 5% | 0.78 | 12 / 245 | 0% | 0 | 0 / 502 |
breast | 4% | 0.68 | 20 / 459 | 0% | 0.01 | 2 / 1118 |
adrenal gland | 4% | 0.64 | 11 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 2% | 0.39 | 32 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 1% | 0.15 | 3 / 328 | 1% | 0.16 | 2 / 178 |
ovary | 2% | 0.30 | 3 / 180 | 0% | 0 | 0 / 430 |
muscle | 1% | 0.19 | 8 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.20 | 7 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007584 | Biological process | response to nutrient |
GO_0010038 | Biological process | response to metal ion |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0009749 | Biological process | response to glucose |
GO_0006096 | Biological process | glycolytic process |
GO_0033198 | Biological process | response to ATP |
GO_0071872 | Biological process | cellular response to epinephrine stimulus |
GO_0051591 | Biological process | response to cAMP |
GO_0042866 | Biological process | pyruvate biosynthetic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004743 | Molecular function | pyruvate kinase activity |
GO_0048029 | Molecular function | monosaccharide binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0030955 | Molecular function | potassium ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PKLR |
Protein name | Pyruvate kinase PKLR Pyruvate kinase isoform 1 Pyruvate kinase PKLR (EC 2.7.1.40) (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase) pyruvate kinase (EC 2.7.1.40) Pyruvate kinase (EC 2.7.1.40) |
Synonyms | PKL PK1 |
Description | FUNCTION: Pyruvate kinase that catalyzes the conversion of phosphoenolpyruvate to pyruvate with the synthesis of ATP, and which plays a key role in glycolysis. . |
Accessions | ENST00000571194.5 [P30613-2] ENST00000434082.3 F8W6W2 A0A4D6DDP3 ENST00000573938.1 A0A4D6DDB2 A0A4D6DDG8 A0A977JB91 ENST00000392414.7 [P30613-2] ENST00000342741.6 [P30613-1] ENST00000572740.1 [P30613-1] A0A0G2JLC7 P30613 |